Gut microbiome in Parkinson's disease: New insights from meta-analysis
Tzi Shin Toh(University Malaya Medical Centre), Ai Huey Tan(University Malaya Medical Centre), B. Brett Finlay(University of British Columbia), Chin‐Hsien Lin(National Taiwan University), Shen‐Yang Lim(Monash University Malaysia), Chieh‐Chang Chen(National Taiwan University), Chun Wie Chong(Monash University Malaysia), Mihai Cîrstea(University of British Columbia), Jeff S. Bowman, Silke Appel‐Cresswell(University of British Columbia)
Cited by 132
Related Papers
Early life antibiotic‐driven changes in microbiota enhance susceptibility to allergic asthma
|EMBO Reports|2012|887
Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease
|Journal of Neuroinflammation|2019|468
Terpene Derivatives as a Potential Agent against Antimicrobial Resistance (AMR) Pathogens
|Molecules|2019|458
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study
|The Lancet Neurology|2011|344